186 related articles for article (PubMed ID: 10698152)
1. Good or evil: CD26 and HIV infection.
Ohtsuki T; Tsuda H; Morimoto C
J Dermatol Sci; 2000 Apr; 22(3):152-60. PubMed ID: 10698152
[TBL] [Abstract][Full Text] [Related]
2. Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1alpha (SDF-1alpha) and SDF-1beta are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage.
Shioda T; Kato H; Ohnishi Y; Tashiro K; Ikegawa M; Nakayama EE; Hu H; Kato A; Sakai Y; Liu H; Honjo T; Nomoto A; Iwamoto A; Morimoto C; Nagai Y
Proc Natl Acad Sci U S A; 1998 May; 95(11):6331-6. PubMed ID: 9600965
[TBL] [Abstract][Full Text] [Related]
3. The structure and function of CD26 in the T-cell immune response.
Morimoto C; Schlossman SF
Immunol Rev; 1998 Feb; 161():55-70. PubMed ID: 9553764
[TBL] [Abstract][Full Text] [Related]
4. Amino-terminal truncation of chemokines by CD26/dipeptidyl-peptidase IV. Conversion of RANTES into a potent inhibitor of monocyte chemotaxis and HIV-1-infection.
Proost P; De Meester I; Schols D; Struyf S; Lambeir AM; Wuyts A; Opdenakker G; De Clercq E; Scharpé S; Van Damme J
J Biol Chem; 1998 Mar; 273(13):7222-7. PubMed ID: 9516414
[TBL] [Abstract][Full Text] [Related]
5. Cell surface peptidase CD26/dipeptidylpeptidase IV regulates CXCL12/stromal cell-derived factor-1 alpha-mediated chemotaxis of human cord blood CD34+ progenitor cells.
Christopherson KW; Hangoc G; Broxmeyer HE
J Immunol; 2002 Dec; 169(12):7000-8. PubMed ID: 12471135
[TBL] [Abstract][Full Text] [Related]
6. Negative regulation of the anti-human immunodeficiency virus and chemotactic activity of human stromal cell-derived factor 1alpha by CD26/dipeptidyl peptidase IV.
Ohtsuki T; Hosono O; Kobayashi H; Munakata Y; Souta A; Shioda T; Morimoto C
FEBS Lett; 1998 Jul; 431(2):236-40. PubMed ID: 9708910
[TBL] [Abstract][Full Text] [Related]
7. Comodulation of CXCR4 and CD26 in human lymphocytes.
Herrera C; Morimoto C; Blanco J; Mallol J; Arenzana F; Lluis C; Franco R
J Biol Chem; 2001 Jun; 276(22):19532-9. PubMed ID: 11278278
[TBL] [Abstract][Full Text] [Related]
8. Processing by CD26/dipeptidyl-peptidase IV reduces the chemotactic and anti-HIV-1 activity of stromal-cell-derived factor-1alpha.
Proost P; Struyf S; Schols D; Durinx C; Wuyts A; Lenaerts JP; De Clercq E; De Meester I; Van Damme J
FEBS Lett; 1998 Jul; 432(1-2):73-6. PubMed ID: 9710254
[TBL] [Abstract][Full Text] [Related]
9. CD26/dipeptidyl peptidase IV differentially regulates the chemotaxis of T cells and monocytes toward RANTES: possible mechanism for the switch from innate to acquired immune response.
Iwata S; Yamaguchi N; Munakata Y; Ikushima H; Lee JF; Hosono O; Schlossman SF; Morimoto C
Int Immunol; 1999 Mar; 11(3):417-26. PubMed ID: 10221653
[TBL] [Abstract][Full Text] [Related]
10. Stromal cell-derived factor-1alpha-induced cell proliferation and its possible regulation by CD26/dipeptidyl peptidase IV in endometrial adenocarcinoma.
Mizokami Y; Kajiyama H; Shibata K; Ino K; Kikkawa F; Mizutani S
Int J Cancer; 2004 Jul; 110(5):652-9. PubMed ID: 15146553
[TBL] [Abstract][Full Text] [Related]
11. Crystal structures of HIV-1 Tat-derived nonapeptides Tat-(1-9) and Trp2-Tat-(1-9) bound to the active site of dipeptidyl-peptidase IV (CD26).
Weihofen WA; Liu J; Reutter W; Saenger W; Fan H
J Biol Chem; 2005 Apr; 280(15):14911-7. PubMed ID: 15695814
[TBL] [Abstract][Full Text] [Related]
12. The significance of hypersialylation of dipeptidyl peptidase IV (CD26) in the inhibition of its activity by Tat and other cationic peptides. CD26: a subverted adhesion molecule for HIV peptide binding.
Smith RE; Talhouk JW; Brown EE; Edgar SE
AIDS Res Hum Retroviruses; 1998 Jul; 14(10):851-68. PubMed ID: 9671214
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 envelope gp120 and viral particles block adenosine deaminase binding to human CD26.
Valenzuela A; Blanco J; Callebaut C; Jacotot E; Lluis C; Hovanessian AG; Franco R
Adv Exp Med Biol; 1997; 421():185-92. PubMed ID: 9330696
[TBL] [Abstract][Full Text] [Related]
14. Regulation of the receptor specificity and function of the chemokine RANTES (regulated on activation, normal T cell expressed and secreted) by dipeptidyl peptidase IV (CD26)-mediated cleavage.
Oravecz T; Pall M; Roderiquez G; Gorrell MD; Ditto M; Nguyen NY; Boykins R; Unsworth E; Norcross MA
J Exp Med; 1997 Dec; 186(11):1865-72. PubMed ID: 9382885
[TBL] [Abstract][Full Text] [Related]
15. The role of CD26/dipeptidyl peptidase IV in cancer.
Havre PA; Abe M; Urasaki Y; Ohnuma K; Morimoto C; Dang NH
Front Biosci; 2008 Jan; 13():1634-45. PubMed ID: 17981655
[TBL] [Abstract][Full Text] [Related]
16. Specific binding of adenosine deaminase but not HIV-1 transactivator protein Tat to human CD26.
Blanco J; Marié I; Callebaut C; Jacotot E; Krust B; Hovanessian AG
Exp Cell Res; 1996 May; 225(1):102-11. PubMed ID: 8635502
[TBL] [Abstract][Full Text] [Related]
17. Kinetic investigation of chemokine truncation by CD26/dipeptidyl peptidase IV reveals a striking selectivity within the chemokine family.
Lambeir AM; Proost P; Durinx C; Bal G; Senten K; Augustyns K; Scharpé S; Van Damme J; De Meester I
J Biol Chem; 2001 Aug; 276(32):29839-45. PubMed ID: 11390394
[TBL] [Abstract][Full Text] [Related]
18. Role of CD26 for CD4 memory T cell function and activation.
Dong RP; Morimoto C
Hum Cell; 1996 Sep; 9(3):153-62. PubMed ID: 9183643
[TBL] [Abstract][Full Text] [Related]
19. Dipeptidyl-peptidase IV-beta, a novel form of cell-surface-expressed protein with dipeptidyl-peptidase IV activity.
Jacotot E; Callebaut C; Blanco J; Krust B; Neubert K; Barth A; Hovanessian AG
Eur J Biochem; 1996 Jul; 239(2):248-58. PubMed ID: 8706727
[TBL] [Abstract][Full Text] [Related]
20. Binding to human dipeptidyl peptidase IV by adenosine deaminase and antibodies that inhibit ligand binding involves overlapping, discontinuous sites on a predicted beta propeller domain.
Abbott CA; McCaughan GW; Levy MT; Church WB; Gorrell MD
Eur J Biochem; 1999 Dec; 266(3):798-810. PubMed ID: 10583373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
